185 related articles for article (PubMed ID: 9527927)
1. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
2. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
3. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
5. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
Gill N; Ashkar AA
Eur J Immunol; 2007 Sep; 37(9):2529-38. PubMed ID: 17668897
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
Jones CA; Taylor TJ; Knipe DM
Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
[TBL] [Abstract][Full Text] [Related]
12. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
Evans IA; Jones CA
J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760
[TBL] [Abstract][Full Text] [Related]
13. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone.
Bhavanam S; Snider DP; Kaushic C
Vaccine; 2008 Nov; 26(48):6165-72. PubMed ID: 18804503
[TBL] [Abstract][Full Text] [Related]
14. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.
Gillgrass A; Chege D; Bhavanam S; Kaushic C
Am J Reprod Immunol; 2010 Apr; 63(4):299-309. PubMed ID: 20070285
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
Morrison LA; Zhu L; Thebeau LG
J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
Morrison LA; Knipe DM
Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
[TBL] [Abstract][Full Text] [Related]
17. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.
Lindqvist M; Persson J; Thörn K; Harandi AM
J Immunol; 2009 May; 182(10):6435-43. PubMed ID: 19414797
[TBL] [Abstract][Full Text] [Related]
18. Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice.
Vagvala SP; Thebeau LG; Wilson SR; Morrison LA
J Virol; 2009 Jan; 83(2):953-60. PubMed ID: 18987142
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
